Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02909842Completed
Randomised, triple-blind trial (2 arms), sponsored by Mahidol University. Primary endpoint: Immune response rate for H1N1, H3N2 and Phu-B virus. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02909842.